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~ 905-11 I OlaMolio Ve~is r  Funotlon In Pedlatrio Patlants 
With ~ ! Olabete~ Mellltus 
Robert Lichtanbmg, Unda Tajeh, William Jasobs, W Patrick Ze]~r, Thomas 
L. McKlaman. Loyola Un~emity, Maywood, it. 
Diastolic Dysfunction, as ~ by Doppler echo Iransmitrel f ow veloci- 
ties, is present in up to 30% of young adult diab~lcs without clinically evident 
heart ~lisease. This "sl~" ventrfcte is not secendmy to clinical I~A~m'tsnsion 
or comnaP/arteP/di~uase. We postulated that the process causing cardiac 
autonomic neuropathy (CAN) is similar in onset to that resulting in ventrioular 
nencompllanco. Slxly+thme Type I diabetics (6-24 ym) were compared to 63 
sex end age matched controls° Forty five had no CAN (DM-CAN), mean age 
13 and duration of diabetes 6 yrs. Eighteen had CAN (DM + CAN), mean age 
20 and duration Of diabetes 15 yre+ In this greup were 6 psttents with early 
CAN, mean age 17 and duration 12 yrs. No pa~ent had cfiflioal hypertension 
or hyperlrophy on echo. Peak Early(E) and Late(A) diaalo|io filling rates, FJA 
ratiO, and atrial filling fraction (FVI %A) were measured. 
Conlrols DM.CAN 0M ÷ CAN OM + Early 
E (cm~) 91:1:10 87 :t: 8 64~:7 72~4 
A (era/s) 41 ~7 44:E6 66~:6 59 :t: 4 
E/A ratio 2+1 :EO.4 2.08 ± 0.5 0.99 :E 0.2 1+224-0.04 
FVI%A 21 :E5 23:~5 44~:6 35±5 
Condus/ens: Patients with Type I DM and CAN have abnormal diastolic 
function. The seventy of the CAN correlates with the severity of the "stiffness'. 
~ Nitroprusslde Cardiac cGMP and Increases 
Reduces ContracUIity in Isoprotemnol-Stimulated 
Rat Hearts 
Richard E. Kisbunde, John Sedoff, Peter M. Scholtz, HaNey R. Weiss+ 
Deborah Reseamh Institute, Browns Mills, NJ: UMDNJ-Robert Wood 
Johnson Medical School, Piscateway, NJ 
Nitric oxide is known to stimulate guenylate cyclase and increase cGMP. 
Besides causing vasodilation, increases in cGMP have been shown to de- 
crease myocardial contractility and oxygen consumption. This study was 
designed to evaluate the hypotheSiS that nitric oxide-induced increases in 
cGMP require elevated background cAMP to produce cerdlac depression. 
Using isolated, Langendorlf-perfused rat hearts, we determined the effects 
of intracomnary infusions of nitroprusside (NP; 10 -3 and 10 -2 M) in the 
absence and presence of Isoprotemnol (ISO; 10 4 M) on cardiac function, 
oxygen consumption, cGMP and cAMP. ISO, with and without NP, caused 
a significant increase in cAMP without altering cGMR This was associated 
with an increase in left ventficular developed pressure from 90 ± 8 to 163 
:E 19 mmHg. NP at both concentrations did not alter cAMP levels, but s|9- 
nificantly increased cGMP ~,'mm about 4.0 to more than 30 pmoVg) in both 
the absence end presence of ISO. In the absence of ISO, NP increased left 
venfficular developed pressure from 93 ~- 9 to 102:1:13 mmHg; however, in 
the presence of ISO, NP decreased left ventdculer developed pre~ut~e from 
181 ~ 212 to 157 :E 9 mmHg. Changes in oxygan cousumption breught about 
by NP tended to parallel the changes in ,eft venlricular developed pressure. 
Therefore, the cardiodepressant effects of NP were only obsenmd against a 
background of inotmpic stimulation with ISO. Furthermore, the effects of NP 
on contractility were not related to changes in CAMP. 
IS Measurable Cycl ic Vaflation of Integrated 
Bacltsoatter Present in All Standa~ Echo-Visws in 
Dilated Cardlomyopalhies? 
Konstantina Boukt, Aioksandra Lange, Przemyalaw Palka, Camel 
M. Moran, Lynn Fenn, M. Pau|iina Ramo, Thomas R.D+ She~, W. 
Norman McDlckan, George FL Sulherlend. Universily of Edinburgh, UK 
The mechanism for the reduced cardiac cycle.dependant variation of inte- 
grated baskscatter (CV/IB) in dilated cardiomyopathies (DCM) is unclear. 
Prior masuremnts of CV/IB in DCM were limited to the sepfum (IVS) and 
left ventricular (LV) posterior wall imaged from the parastan~l long-axis view 
(LX). TO determine if changes in CV/IB me present in all LV wells and reflect 
regional and global structural changes within the myocardium, CV/IB was 
measured from LX, apical 4- (4C) and 2-chambsr (2C) views in 26 DCM pts 
(mean age 58:1:9 ys; ejection fraction 29 ± 10%) and compared to 30 age. 
matched non'nals (N). Using a 2D acquisition, CV/IB was measured from 16 
ragtons-of-interest (ROI) ~'lh~n the LV: basal (B) and m~ (M) segments from 
LX and B, ivl and apical segments from 4C and 2C visws. CV/IB was present 
in 100% ROIS in N and in 87% in OCM. The mean value of CV/IB, averaged 
from all ROIS in DCM was significantly reduced compared to N (3 ± 2.5 dB 
vs 5 :E 2.9 dB, ~ ~, 0,0001). The N group demonstrated marked regional 
va~l i ty  in the magnitude of CV/1B. Although DCM patients had globally 
hypocont~ctlle LV's, CVIIB was not equa~ reduced in a~ ROIS. The ROts 
located w~Itin the M-IVS, M- and apica~K~f...edor wall ~ not demonslreto 
anY slgalrmant ddfemnce when ~ to N+ Th/s may be mlatod to the 
hetsmgeneous l:,attem of the mmopamologioal charges of gre myocerdimn 
in DCM. These t i~  indicate ~ a multi-view approach to record CV/IB 
can be used to ~eremi~e nom~ h'om myopa~c myocar¢~n and can 
quantify regional differences in ~ contractile pe~ormanca of the IV. 
T h e / i n t  of Systemic Vascular Compliance 
uunng GardlaC Output Measurement o Evaluate 
Cardisvemcular Loading Status 
Wal-Chih Hu, Tsui.Ueh Hsu, Todd Bdnton, U-Ching Tai, Shiu-Shio Chlo, 
Shil~Pu Wang, Mau-Song Chang, Chun-Peng U,j. Veterans General 
Hospttaf- Taipei, Taiwan, FL O.C. 
Systsm~c vascular compliorlco (SVC), dVldR is an important index of car- 
diovascular loading status. SVC was determined using cardiac output (CO) 
derived by thermo, dilution and ne~invasive pulse pressure (PP) and heart 
rate (HR) measurement obtained by a new osciPometric technology, [SVC = 
CO/(PPHR)]. SVC measurement obtained by this methed were compared 
to the affeceve arterial e~astanca (F.a) chtalne~ by m~ro-rmmm.cetor ~ped 
catheter ~n 30 myocan~ e~tion (M0 ~d 26 con~ p~ts .  By ~ ,  
SVC corrasp0ndS invarsaly to Ea whk:h was detemlined by the retie Of teft 
ventricle developad pressure to almke vofume. A gcod corrosion (r= 0.85) 
was observed between SVC and 1/Ea (top ligum)+ In order to evaluate the 
reisttonship between btood pressure load and ~ e r  ioac~ng ststus, 
SVC was cem~ared to mean mteri~ pmastm~ (MAP) in both MI and contrel 
patients+ The retaken between SVC and MAP is best Idled ~ a second 
order polynomial (r = 0.77) and the data of both groups follows the same 
tiffing func~on (lower figure), 
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The resutts suggest thaZ SVC can he ~ assessed dering cerdiac 
output m e ~  ubTzzing a new nen-tnvaalve blood pressure and heart 
rate technology and results are not signifioantly affected by disease state. 
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• 0 6 " • ' •  Prevelance of Left Verdflcuisr OyMunctton In Female Carders of Duchenne and Becker Muscular 
Oyslrophy 
Atmette C. Bratms, Edo M, H c o ~  ~ Bakker, Arthur A. Wilde, 
Marline de %r~,  Pen A. van der Wouw. Academ/c ~ Centre, 
Amsterdam, Th~ ~ -  Unh~dtyofLe/0@n, Le/dea, The 
N e ~  
Introduction: Several reports have staled cardiac invo~ement i  poss~te 
female carders of Ducherme (DMD) and Becket (BMD) muscular dyMrophy. 
As ~rders can now be pes~ identified by DNA analys"~s It hes bsceme 
passibte to study LV function in DNA-preven and obtigatory O/BMD ca,'zters. 
Methods: BMO and DMD carriem in the age of 18--60 years, registered at 
the depL of Human Genetics in Letde~ were invited to participate in the study. 
Carrier status was established by pedigree or DNA analysis. Women w~ 
hype~ension, coron~y dsease, valve dysfunc~n, or severe co~d~dlty 
were excluded. Left vantdeular (LV) function arid wall motion was assessed 
by M-mode nd 2-D Uansthera~c .  
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Results: A total of 129 women ware included: 85 DMD and 44 BMD carriers. 
Thalr mean age was 37 ± 10 years. Mean LVend diastolic diameter (LVED) 
was 50 -I- 5 ram, mean shortening fraction (SF) was 37 d: 7%, and mean 
Et0oint septal separation (EPSS) was 5 ~ 2 mm. None had more than mild 
mitral, aort~ or tricuspid rogu~itatlen. Fourteen DMD and 4 BMD Carders 
had LV abnormalities. LV dilatation (LVED > 57 ram) was observed in 8 
DMD, reduced SF (< 27%) in I BMD and 3 DMD, increased EPSS (> 8 mm) 
in 1 BMD and 6 DMD, and 4 DMD had regional wag motion abnom~itias. 
Diastolic dysfunction (E/A ratio < 1) was noted in 2 BMD and 2 DMD. Six 
DMD carriers were considered to have dilated cardiomyopothy. 
Conclusion: LV dysfunctino is more frequently seen in DMD as compared 
to BMD Carriem. Nthough most carders appear to have normal LV function, 
manifest cardiomyopathy isseen in 7% of DMD caniem. 
Lymphocytic _1~. cardtltis In Childhood: Incidence 
and Outcame wollowing uual  Therapy 
Immunosuppmselon 
Sabine Kieinert, Palriota Kelly, James Wilkinson, Chung-Wo Chow, 
Robert Weinfraub. Royal Children's Hospital, Melbourne, Australia 
The true incidence of ~ i t i s  in children with acute d~ted ca~liomyopa- 
thy (DCM) is unkswn and reported outcome with supportive therapy alone 
is variable. Although animal models suggest that immune mechanisms play 
an important role in the pathoEP-rL~, i-~ of .myocarditis, the efficacy of immune- 
suppression in humans has not been established. 
Early endomyocardial b~psy was performed 26 consecutive children with 
acute DCM. Group i patients (n = 8; 31%) with "definite" myocarditis (lym- 
phocytic infiltrate + myocardial necrosis) were treated with cydaspodne and 
prednisoione, with follow-up biopsies prior to withdrawal of therapy. Group 
It patients (n = 3; 11%) with "berdedina" myocarditis (lymphec~ic infiltrate 
alone) and Group 01 (remaining patients; n = 15; 58%) received conven- 
tional medical therapy. Echocardlographic Z scores were derived from 300 
age-matched control subjects. Them were no non-invasive features ~at 
distinguished Group I patients from the other groups. 
Group I Group lit P value 
Early LVEOd Z score S.O :1:0.6 4.1-1- 0.5 NS 
Early FS Z score -5.2 :E 0.3 -5.9 :E 0.3 NS 
Late LVEDd Z score 0.8 =E0.3" 3.0:E0.8 <0.05 
Late FS Z score -0.9:E0.4 ~ -2.69=0.7 0.06 
Echo ~p/  8/8 5/15 < 0.05 
Death 0/8 4/15 NS 
*P < 0.01 by compar;son ~ ear;y Z so,re 
Two Group I patients had late echecerdiogrephic and biopsy worsening 
which responded to reinstits~on of immunosuppressicn. 
Lymphocytic myocordftis is frequent in children with acute DCM. Dual 
therapy immunosuppression isassociated with a faveurabic outcome. These 
preliminary data point to the need for a specific controlled trial of dual therapy 
immunosuppreSSicn i poedistdc patients. 
] '9 -~ Altered Myocardial Phenotype Following 
Mechanloal Support in Humans Wlth Advanced 
Cardiomyopathy 
Gregory Aitemose, Vedim Gdtsus, Bruce Goldman, Valluvan Jeevana~,  
Kenneth Marguties. Temple University School of Medicine, Philadelphia, PA 
Left vantdcotar assist devices (LVAD) provide lifesaving circulatory support 
to patients 8waiting orthotopio heart transplantation. To date, the extent o 
which sustained mechanical unloading alters the phenotype of pathologic my- 
ocardial hype~rophy in dilated Cardiomyopathy is unknown. Therefore, we 
examined LV size, myocyts msrpheme W and atrial natduretic peptide (ANP) 
immunoreactlvtty in eight patients with advanced ilated celdiomyopathy be- 
fore and after LVAD support. The mean duration of CHF was 18 ~ 5 months, 
and LVAD support averaged 42 4- 4 days prior to head transplantation. 
Pra-LVAD Post-LVAD 
Mean PA pressure (mmHg) 41 :t: 2 23 ~: 3" 
PA wedge pressure (mmHg) 29 :E 3 17 :t: 3* 
Cardiac Index (1/mitring) 1.9 .-4:0,2 2,8 :E 0.2* 
LV shod axis diameter (cm) 7.8 9= 0.9 5.5 ± 0.5* 
LV Mass (grams) 339 :E 60 205 :E 2P 
Myocyle diameter (~ml 28.1~- 0.9 21.7:E 0.6" 
All values mean 9= SEM, "p < 0,05 vS. Pre.LVAD 
As shown above, hemodynamio support and unloading with the LVAD re. 
ducad echocardiographlcally determined LV dilation and LV mass. Minimum 
myocyte diameter at the level of the nucleus also decreased foflOwing LVAD 
support. Overall left vectricuisr ANP immunopositivity decreased from 48% 
at LVAD placement to 12% at transplantation (p < 0.05), and there was a 
close correlation (r = 0.82, p < 0,001 ) between left ventricular mass and ANP 
immunopositivity before and after LVAD support, These studies demonstrate 
remarkable t.v plasticity even In the presence of advanced ¢ardiomyopa- 
thy, Reductions in ventdcular ANP Irnmunostalnlng also suggest that LVAD 
support induces a unique change in the phenotype of pathologic cardiac 
hypeerophy. 
~ Idlol~lhl¢ Familial Dilated Card iomyopsthy:  
Idenffiying Early Disease In Asymptonlatlc 
Relatives 
M. Kammn Baig, Jonathan H. Goldman, Philip J. Keeling, Aman S. Coonar, 
Mitautoshi Yamada, Allda LR  Cafodo, William J. McKenna, St Georges 
Hospital, London, UK 
Background ~ Familial disease is present In > 25% of patimP, s with dilated 
cerdiomyopathy (DCM). The ~hility to identify esymptomatio relatives with 
early disease is a malor goat in understanding pathogenesls and improving 
management. 
Method--We assessed 321 asymptomatio relatives (mean age 35 =1:15, 
t93 male) of 70 DCM patients 0NHO criteria). 
Resu l ts -  59 (20%) had LV enlargement (LVE = > 11L>~ predicted 
LVEDd), 21(7%) had depressed fractional shortening (dfs = FS < 25%) 
and the remainder had normal dimensions and contractility (NOR). Diss- 
tolio dysfunction (AbN E/A ratio) was present in 40 (68%) LVE retatives and 
60(41%) NOR. LVE's had lOwer FS (33:1: 5% vs 35 :J: 6=, p < 0.05), and 
longer total QRS (98 =1:12 ms vs 94:1:10 ms, p = 0.05), than those with 
normal aches. A greater proportion of LVE had abnormal VO2 Max (< 80% 
predicted) compared to NOR (6.10% vs 7.4%; p < 0,05). Dta's had larger 
LVDd% predicted (112 -4-13 vs 102 ~ 7, p < 0,001), and lower RMS VOltage 
(34 :J: 18 my vs 58 :E 40 ray, p = 0.05) than NOFL The mean F-/A ratio of 
relatives (n = 100) was tower than predicted E/A ratio, (1.55 + 0.83 vs 1.75 ± 
0.44, p = 0,03) and LVE had lower E/A ratio than NOR (1.29 :E 0.72 vs 1,60 
:E 0.71, p = 0.04). Over 27.5 :E 14.3 months follow*up, 9 relatives developed 
DCM and one (m3h mild palpitations) died suddenly. 
Conclusions --Asymptomatic relatives commonly have echocardiographte 
abnormalities; the metabolic and SA-ECG abnormalitiee also obsozved sug- 
gest these two echo abnormalities may represent early DCM. 
~ Chronic Adenos ine  Rec~.lPt_Or B lockade Prevents 
Attenuation o f  Adrenergl© e(seponsivenesez in Left 
Ventrtculor Hypertrophy 
Eugene S. Chang, Thao E. Meyer, James G. Dobson Jr, Richard A. Fenten, 
Gerard P, Audgemma, William H. Gaasch. Univemity Massachusetts 
Medical Center,, Worcester, MA 
Left ventricular hypertrophy (LVH) is associated with reduced adranergic re- 
sponsiveness (AR). Acutely, adenosine (ADO) levels increase in respoilse 
to increased myocardmt work and exhibit an anttadrenergic action. To deter- 
mine whether chronic blockade of the ADO receptor or ADO uptake would 
alter AR in LVH, rats with LVH, induced by supmrenal aortic banding (B), 
and sham operated rats (S) were each subdivided into 3 treatment groups, 
with the last dose given 24 hours before sasflflce: theophylline (ADO mcepter 
blocker; 20 mg/kg tp bid, groups BT, ST), dlpyfldemole, (ADO uptake blocker; 
5 mg/kg ip bid, groups BD, SD), or 0.9% NaCI (2 mt/kg iD bid, groups BN, 
SN). At 9 weeks, hearts were perfusad with physiological saline solution at 
a pressure predetermined by the carotid blood pressure. AR to isopretorenol 
was assessed at 4 doses. Data are shown as mean :E SEM; MBP = Mean 
BP (mmHg); LVwt ,= dry LV weight (mg/g body weight); ~dPIdt = maximal 
change in +dP/dt (mmHg/s); ECso = log M concentration at 50% of maximal 
response; 
BT(n21) BD(n19) BN(n16) ST(n16) 
MBP 134 125 137 94 
:~51 ±91 ±61" 9=5 
LVwt 0.57 0.58 0.61 0,42 
0,021 + 0.02 t ± 0,02 t 9= 0.01 
LzdP/dt 3587 2832 2999 4461 
~: 161 :t:286 t :E 2121 9=270 
ECS0 -8.14 -8.05 -8,14 -8.21 
-I-0.02 ±0.07" -I-0,03 ±0.03 







± 369 ± 258 
-8.23 -8.23 
=1:0.02 4- 0.02 
Conclusions: Data confirm reduced AR in LVH. Chronic blockade of ADO 
uptake reduces the AR, while chronic recaptor blockade prevents attanua~n 
of AR in LVH. 
